Tech Transfer Roundup: How Johns Hopkins Optimizes Its Life Science Start-Ups
The Baltimore university relies on an extensive infrastructure for tech transfer, and has a high volume of output to show for it. Recent tech transfer deals include Spark, Spotlight, Achilles, Biohaven, Cantabio and Renova, Zucara and Heat Biologics.
You may also be interested in...
A review of biopharma start-up dealmaking and financing from October through December 2016, based on data from Strategic Transactions.
Deal snapshot: Resolving a loose end from its 2014 buyout of Auxilium, Endo acquires all rights to Xiaflex, along with approved cellulite therapy Qwo.
During Q3, biopharmas brought in an aggregate $36.6bn in financing and device company fundraising totaled $3.3bn; while in vitro diagnostic firms and research tools players raised $3.4bn.